Benjamin Burnett
Stock Analyst at Stifel
(1.97)
# 2,853
Out of 4,831 analysts
71
Total ratings
40.82%
Success rate
-9.24%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Benjamin Burnett
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FATE Fate Therapeutics | Maintains: Hold | $5 → $3 | $1.00 | +200.00% | 3 | Mar 6, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Hold | $53 → $49 | $37.22 | +31.65% | 6 | Feb 13, 2025 | |
| ACLX Arcellx | Maintains: Buy | $83 → $122 | $58.25 | +109.44% | 5 | Oct 18, 2024 | |
| BEAM Beam Therapeutics | Maintains: Buy | $66 → $69 | $18.05 | +282.27% | 2 | Sep 11, 2024 | |
| IDYA IDEAYA Biosciences | Maintains: Buy | $63 → $68 | $17.45 | +289.68% | 7 | Sep 10, 2024 | |
| ALLO Allogene Therapeutics | Maintains: Hold | $4.4 → $4.6 | $1.13 | +307.08% | 5 | May 14, 2024 | |
| ATRA Atara Biotherapeutics | Maintains: Hold | $120 → $58 | $6.68 | +760.78% | 4 | Apr 1, 2024 | |
| DTIL Precision BioSciences | Maintains: Buy | $690 → $780 | $5.15 | +15,060.35% | 2 | Sep 10, 2021 | |
| BLUE bluebird bio | Upgrades: Buy | $1,880 → $1,400 | $3.31 | +42,196.07% | 3 | Mar 27, 2020 | |
| RVMD Revolution Medicines | Maintains: Buy | $78 → $64 | $39.95 | +60.20% | 5 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $94 | $46.35 | +102.80% | 7 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $4 | $1.43 | +179.72% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $1.35 | +640.74% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $1.79 | +1,296.65% | 11 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 → $24 | $0.71 | +3,280.28% | 2 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $16 | $0.46 | +3,378.26% | 1 | Jan 6, 2021 |
Fate Therapeutics
Mar 6, 2025
Maintains: Hold
Price Target: $5 → $3
Current: $1.00
Upside: +200.00%
CRISPR Therapeutics AG
Feb 13, 2025
Maintains: Hold
Price Target: $53 → $49
Current: $37.22
Upside: +31.65%
Arcellx
Oct 18, 2024
Maintains: Buy
Price Target: $83 → $122
Current: $58.25
Upside: +109.44%
Beam Therapeutics
Sep 11, 2024
Maintains: Buy
Price Target: $66 → $69
Current: $18.05
Upside: +282.27%
IDEAYA Biosciences
Sep 10, 2024
Maintains: Buy
Price Target: $63 → $68
Current: $17.45
Upside: +289.68%
Allogene Therapeutics
May 14, 2024
Maintains: Hold
Price Target: $4.4 → $4.6
Current: $1.13
Upside: +307.08%
Atara Biotherapeutics
Apr 1, 2024
Maintains: Hold
Price Target: $120 → $58
Current: $6.68
Upside: +760.78%
Precision BioSciences
Sep 10, 2021
Maintains: Buy
Price Target: $690 → $780
Current: $5.15
Upside: +15,060.35%
bluebird bio
Mar 27, 2020
Upgrades: Buy
Price Target: $1,880 → $1,400
Current: $3.31
Upside: +42,196.07%
Revolution Medicines
Apr 1, 2025
Maintains: Buy
Price Target: $78 → $64
Current: $39.95
Upside: +60.20%
Jan 24, 2025
Maintains: Buy
Price Target: $90 → $94
Current: $46.35
Upside: +102.80%
Dec 13, 2024
Maintains: Buy
Price Target: $9 → $4
Current: $1.43
Upside: +179.72%
Jun 3, 2024
Maintains: Buy
Price Target: $7 → $10
Current: $1.35
Upside: +640.74%
Sep 15, 2023
Reiterates: Buy
Price Target: $25
Current: $1.79
Upside: +1,296.65%
Jun 28, 2021
Upgrades: Buy
Price Target: $22 → $24
Current: $0.71
Upside: +3,280.28%
Jan 6, 2021
Initiates: Hold
Price Target: $16
Current: $0.46
Upside: +3,378.26%